Apr 15, 2020 — On April 15, 2020, Accelerate Diagnostics and BioCheck announced a commercial supply and collaboration agreement by which Accelerate will distribute the BioCheck MS-FAST system and BioCheck SARS-CoV-2 tests in North America, Europe, and the Middle East. The BioCheck MS-FAST system, a fully automated chemiluminescence immunoassay analyzer, and the BioCheck SARS-CoV-2 chemiluminescence-based tests are capable of […]
Clinicians at Moffitt Cancer Center make a difference for patients by optimizing antibiotic therapy earlier
Mar 06, 2020 — Mary Meyer, a transplant patient at Moffitt Cancer Center recently experienced first-hand how beneficial same-day antimicrobial susceptibility results can be. Ms. Meyer was treated in the Moffitt Urgent Care center for an unknown infection. Doctors there tested her blood using the Accelerate Pheno system, a new diagnostic system that can identify bacteria and provide antimicrobial […]
Accelerate Diagnostics Reports Fourth Quarter 2019 Financial Results
Feb 27, 2020 — Accelerate Diagnostics, Inc. announced financial results for the fourth quarter and full year ended December 31, 2019. “Our contracted instrument trajectory continued over the course of 2019 as we doubled our global contracted instrument base by signing 304 instruments, including 137 units during the fourth quarter. Our full-year revenue was short of expectations as multi-site […]
HealthLeaders: Allegheny Health Network benefits from new rapid test
Feb 10, 2020 — From HealthLeaders: For the past eight months, the team at Allegheny Health Network has been using the Accelerate Pheno test system to analyze bloodstream infections and determine the best antibiotic therapy for sepsis patients. Sepsis is the body’s extreme reaction to an infection, which can result in life-threatening symptoms such as multiple organ failure. Annually, […]
See all news
Enter your email address below for access to photos, logos and videos.
Connect with us
Want to hear when we announce our next event? Stay up to date with Accelerate by joining our mailing list.Sign up today
February 3-6, 2020
Dubai World Trade Centre, UAE
December 16-17, 2019
Palais des Congrès de Paris, France
December 4-6 2019
Hamburg Messe, Germany
November 11-14, 2019
November 9-12, 2019
Palacongressi Di Rimini, IT
October 2-6, 2019
Over the past several years, Accelerate Diagnostics, together with our scientific collaborators, conducted numerous scientific studies supporting the exciting capabilities of our ID/AST System. Many of these studies resulted in posters presented at international conferences and peer-reviewed publications. We have conducted over 87,000 internal identification and susceptibility experiments across a panel of more than 20 of the most clinically prevalent species in sample types such as positive blood cultures and BALs. These studies demonstrated compelling performance versus reference and comparator methods, the results of which have been consistently duplicated by our clinical research partners. Below you will find links to some of these posters and publications.
These publications may include information from one or more organism/antimicrobial combinations that are research use only and not for use in diagnostic procedures.
Certain uses of devices included in these publications may not have been approved or cleared by the U.S. Food and Drug Administration or other regulatory bodies.
See product labeling for instructions for use, warnings, and limitations specific to each product and region.Okay, I understand. Show me the publications.